Lipodystrophy in HIV/AIDS patients with different levels of physical activity while on antiretroviral therapy;Lipodistrofia em pacientes com HIV/AIDS com diferentes hábitos de atividade física, em uso de terapia antirretroviral

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 4, 2011, Pages 420-424

  Segatto, Aline Francielle Mota ^a   Freitas Jr , Ismael Forte ^a   dos Santos, Vanessa Ribeiro ^a   Alves, Kelly Cristina Pinto ^b   Barbosa, Dulce Aparecida ^b   Filho, Alexandre Martins Portelinha ^c   Monteiro, Henrique Luiz ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Departamento de Infectologia   (Brazil)

Author keywords

Body composition; HIV AIDS; Lipodystrophy; Physical activity

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; SITTING; TREATMENT DURATION; VIRUS LOAD;

ABSORPTIOMETRY, PHOTON; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; BRAZIL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; QUESTIONNAIRES; RISK FACTORS; SEDENTARY LIFESTYLE; STATISTICS, NONPARAMETRIC; VIRAL LOAD;

EID: 81455150182     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822011000400004     Document Type: Article

References (31)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining Morbidity and mortality among patients with advanced humab immunodeficiency vírus infection. N Engl J Med 1998; 338:858-860.
2. Crum NC, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, et al. Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons. Analysis of the Pre-, Early, and Late HAART (Highly Active Antiretroviral Therapy) Eras. J Acquir Immune Defic Syndr 2006; 41:194:200.
3. Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, et al. Longterm immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 2008; 22:291-302.
4. Bedimo RJ. Body-Fat Abnormalities in Patients With HIV: Progress and Challenges. J Int Assoc Physicians AIDS Care (Chic Ill) 2008; 7:292-305.
5. RS. Lipodistrofia em pacientes sob Terapia Anti-Retroviral: subisídios para o cuidado de enfermagem a portadores de HIV-1. [dissertação]. [Ribeirão Preto]: Escola de Enfermagem de Ribeirão Preto; 2008. 102 p.
6. Mutimura E, Stewat A, Rheeder P, Crowther N. Metabolic Function and the prevalence of lipodystrophy in a population of HIV-Infected african subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 46:451-455.
7. Potthoff A, Brocmeyer NH, Gelbrich G, Neuhaus K, Stefa E, Reinsch N, et al. Lipodystrophy - a sing for metabolic syndrome in patients of the HIV- HEART study. J Dtsch Dermatol Ges 2010; 8:92-98.
8. Coll B, Parra S, Villaverde CA, Grootric AG, Montero Ml, Tous M, et al. HIVinfected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1. Cytokine 2006; 34:51-55.
9. Mutimura E, Crowther NJ, Cade TW, Yarasheski KE, Stewart A. Exercise training reduces central adipodity and improves metabolic índices in HAART-treated HIV-positive subjects in Rwanda: A randomized controlled Trial. AIDS Res Hum Retroviruses 2008; 24:15-23.
10. Robinson FP, Quinn LT, Rimmer JH. Effects of high-intensity endurance and resistence exercise on HIV metabolic abnormalities: a pilot study. Biol Res Nurs 2007; 8:177-185.
11. Lindegaard B, Hansen T, Hll van G, Plomgaard P, Ditlevsen S, Gerstoft J, et al. The effect of strength and endurance training on insuli sensitivity and fat distribution in human immunodeficiency vírus infected patients with lipodystrophy. J Clin Endocrinol Metab 2008; 93:3860-3869.
12. Terry L, Sprinz E, Stein R, Medeiros NB, Oliveira J, Ribeiro JP. Exercise training in HIV-1infected individuals with dyslipidemia and lipodystrophy. Med Sci Sports Exerc 2006; 38:411-417.
13. Thoni GJ, Fedou C, Brun JF, Fabre J, Renard E, Reynes J, et al. Reduction of fat accumulation and lip disorders by individualized light aerobic training in human immunodeficiency vírus infected patients with lipodystrophy and/or dyslipidemia. Diabetes Metab 2002; 28:397-404.
14. Florindo AA, Latorre MRDO, Jaime PC, Segurado AAC. Leisure time physical activity prevents accumulation of central fat in HIV/AIDS subjects on highly active antiretroviral therapy. Int J STD AIDS 2007; 18:692-696.
15. Ramírez-Marrero FA, Smith BS, Meléndez-Brau N, Santana-Bagur JL. Physical and Leisure Activity, Body Composition, and Life Satisfaction in HIV-Positive Hispanics in Puerto Rico. J Assoc Nurses AIDS Care 2004; 15:68-77.
16. Domingo P, Sambeat MA, Pérez A, Ordoñez J, Rodríguez J, Vázquez G. Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor. Antivir Ther 2003; 8:223-231.
17. Centro de Estudos do Laboratório de Aptidão Física de São Caetano do Sul. Questionário Internacional de Atividade Física - IPAQ (versão curta). [cited 2010 jun 8]. Available from: http://www.celafiscs.institucional.ws/65/questionarios.html/.
18. Sjöström M, Ainsworth B, Bauman A, Bull F, Craig C, Sallis J. Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ) - Short and Long Forms. [citede 2010 jun 8]. Available from: http://www.ipaq.ki.se/scoring.pdf/.
19. Mutimura E, Stewart A, Rheeder P, Crowther NJ. Metabolic function and prevalence of lipodystrophy in a population of HIV-infected african subjects receiving highly active antiretroviral therapy. J Acquir Defic Syndr 2007; 46:451-455.
20. Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, et al. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med 2003; 4:293-301.
21. Diehl LA, Dias JR, Paes ACS, Thomazini IMC, Garcia LR, Cinagawa E, et al. Prevalência da Lipodistrofia Associada ao HIV em Pacientes Ambulatoriais Brasileiros: Relação com Síndrome Metabólica e Fatores de Risco Cardiovascular. Arq Bras Endrocrinol Metab 2008; 52:658-667.
22. Sansores CC, Rivero AS, Rendón JCS, Rodrígues ID, Biachi RG, Martínez PG. Síndrome de lipodistrofia em pacientes com infección por VIH que reciben tratamiento antirretroviral. Med Int Mex 2008; 24:8-15.
23. Tien PC, Grunfeld C. What is HIV-associated lipodydtrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis 2004; 17:27-32.
24. Martinez E, Mocroft A, Garcia-Viejo MA, Pérez-Cuevas J, Blanco JL, Mallolas J, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a spective cohort study. Lancet 2001; 357:592-598.
25. Lichtenstein KA. Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immuni Defic Syndr 2005; 39:395-400.
26. Perna FM, La Perriere A, Klimas N, Ironson G, Perry A, Pavone J, et al. Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Med Sci Sports Exerc 1999; 31:973-979.
27. La Perriere A, Klimas N, Fletcher MA, Perry A, Ironson G, Perna F, et al. Changes in CD4+ cell enumeration following aerobic exercise training in HIV-1 disease: possible mechanisms and pratical applications. Int J Sports Med 1997; 18 (suppl 1):56-61.
28. Santos EC, França Jr I, Lopes F. Qualidade de vida de pessoas vivendo com HIV/AIDS em São Paulo. Ver Saúde Pública 2007; 41:64-71.
29. CL. Estilo de vida dos portadores do vírus HIV atendidos no município de Florianópolis. [dissertação]. [Florianópolis]: Universidade Federal de Santa Catarina; 2003. 107 p.
30. Santos CP, Felipe YX, Braga PE, Ramos D, Lima RO, Segurado AC. Self-perception body changes in persons living with HIV/AIDS: prevalence and associated factors. AIDS 2005; 19:14-21.
31. Seidl EM, Machado ACA. Bem-estar psicológico, enfrentamento e lipodistrofia em pessoas vivendo com HIV/AIDS. Psicol Estudo 2008; 13:239-247.